Pediatric DRV/r (pDRV/r) FAQs
A framework to support new product introduction in national health systems
Resource Library


- Sep 6
Pediatric DRV/r (pDRV/r) Product Profile

- Jun 5
Pediatric ALD (pALD) FAQs

- May 30
pALD Product Profile

- May 30
Pediatric Treatment Optimization Roadmap

- May 24
GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

- May 16
CAB Case Studies from Ethiopia

- May 4
The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study

- Feb 16
CAB Case Studies from Tanzania

- Feb 16
CAB Case Studies from Zambia

- Feb 16
CAB Case Studies from Nigeria

- Feb 16
CAB Case Studies from Uganda

- Jun 23, 2022
EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG

- Apr 4, 2022
Pediatric DTG FAQs for Caregivers and Communities (English, French, Swahili)

- Apr 4, 2022
Pediatric DTG Administration Poster for Caregivers (English, French, Swahili)

- Apr 4, 2022
Pediatric DTG Pocketbook for Caregivers (English, French, Swahili)

- Feb 9, 2022
WHO Pediatric ARV Dosing Dashboard

- Nov 2, 2021
Pediatric DTG Jingle (English)

- Nov 2, 2021
Pediatric DTG Social Media Graphic (English, French)

- Oct 18, 2021
Pediatric DTG Healthcare Worker Resources